Coeptis Therapeutics Hldgs Inc (COEP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 13,724 | 100 | 156 | 142 | 68 |
| Operating Income | -13,649 | -100 | -156 | -142 | -68 |
| Other Income | -16,247 | 4,277 | -1,648 | 14,214 | -17,211 |
| Pre-tax Income | -29,895 | 4,177 | -1,804 | 14,073 | -17,279 |
| Net Income Continuous | -29,895 | 4,177 | -1,804 | 14,073 | -17,279 |
| Net Income | $-29,895 | $4,177 | $-1,804 | $14,073 | $-17,279 |
| EPS Basic Total Ops | -59.80 | 9.00 | -3.80 | 30.00 | N/A |
| EPS Basic Continuous Ops | -164.42 | 8.91 | -19.24 | 150.11 | -184.31 |
| EPS Diluted Total Ops | -59.80 | 9.00 | -3.80 | 30.00 | N/A |
| EPS Diluted Continuous Ops | -164.42 | 8.91 | -19.24 | 150.11 | -184.31 |
| EBITDA(a) | $-13,724 | $-100 | $-156 | $-142 | $-68 |